AF
RARE icon

Allworth Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History

Allworth Financial’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Buy
4,699
+2,664
+131% +$66.2K ﹤0.01% 1655
2026
Q1 		$42.6K Buy
2,035
+1,553
+322% +$35K ﹤0.01% 2441
2025
Q4 		$11.1K Buy
482
+203
+73% +$6.68K ﹤0.01% 3198
2025
Q3 		$8.39K Buy
279
+30
+12% +$900 ﹤0.01% 3251
2025
Q2 		$9.05K Buy
249
+127
+104% +$4.58K ﹤0.01% 2945
2025
Q1 		$4.59K Buy
122
+105
+618% +$4.37K ﹤0.01% 2808
2024
Q4 		$730 Hold
17
– – ﹤0.01% 3497
2024
Q3 		$945 Hold
17
– – ﹤0.01% 3240
2024
Q2 		$724 Sell
17
-2
-11% -$85 ﹤0.01% 3269
2024
Q1 		$888 Buy
19
+12
+171% +$566 ﹤0.01% 3120
2023
Q4 		$335 Sell
7
-33
-83% -$1.28K ﹤0.01% 3217
2023
Q3 		$1.43K Buy
40
+29
+264% +$1.15K ﹤0.01% 2697
2023
Q2 		$508 Buy
11
+7
+175% +$325 ﹤0.01% 2898
2023
Q1 		$161 Sell
4
-10
-71% -$429 ﹤0.01% 3052
2022
Q4 		$649 Buy
14
+9
+180% +$354 ﹤0.01% 2567
2022
Q3 		$0 Buy
+5
New +$257 ﹤0.01% 3031
2022
Q2 		– Sell
-11
Closed -$1K – 2730
2022
Q1 		$1K Sell
11
-97
-90% -$6.75K ﹤0.01% 1996
2021
Q4 		$9K Sell
108
-3
-3% -$244 ﹤0.01% 1419
2021
Q3 		$10K Buy
+111
New +$10K ﹤0.01% 1344

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Allworth Financial's RARE Position: Q2 2026 in Review

Allworth Financial increased its Ultragenyx Pharmaceutical (RARE) stake by 131% in Q2 2026, buying an estimated $66.2K and bringing the position to 4,699 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #1655.

Allworth Financial first reported a position in RARE in Q3 2021 and has held it in 19 quarters since. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Allworth Financial held 4,699 shares of Ultragenyx Pharmaceutical worth $157K as of Q2 2026.
  • Allworth Financial bought 2,664 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $66.2K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1655 holding.
  • Allworth Financial first reported a position in Ultragenyx Pharmaceutical in Q3 2021 and has held it in 19 quarters since.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.